Conde-Knape makes the future of pharmaceuticals possible at Novo Nordisk

The world has been her playground, and now, Karin Conde-Knape is using her international experiences as the woman in charge of Global Drug Discovery at Novo Nordisk.
BY FREDERIK TILLITZ, TRANSLATED BY CATHERINE BRETT AND DANIEL PEDERSEN

Karin Conde-Knape became the senior vice president of global drug discovery at Novo Nordisk a little over a year ago. Here, she's in charge of preliminary research withinin several therapy areas that are of interest to the pharmaceutical giant.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading